全文获取类型
收费全文 | 52412篇 |
免费 | 4452篇 |
国内免费 | 2404篇 |
专业分类
耳鼻咽喉 | 537篇 |
儿科学 | 808篇 |
妇产科学 | 534篇 |
基础医学 | 6330篇 |
口腔科学 | 951篇 |
临床医学 | 6028篇 |
内科学 | 7730篇 |
皮肤病学 | 971篇 |
神经病学 | 2709篇 |
特种医学 | 2597篇 |
外国民族医学 | 7篇 |
外科学 | 5157篇 |
综合类 | 7262篇 |
现状与发展 | 11篇 |
一般理论 | 3篇 |
预防医学 | 4103篇 |
眼科学 | 1041篇 |
药学 | 5712篇 |
36篇 | |
中国医学 | 2885篇 |
肿瘤学 | 3856篇 |
出版年
2024年 | 147篇 |
2023年 | 609篇 |
2022年 | 1678篇 |
2021年 | 2346篇 |
2020年 | 1618篇 |
2019年 | 1472篇 |
2018年 | 1600篇 |
2017年 | 1592篇 |
2016年 | 1707篇 |
2015年 | 2644篇 |
2014年 | 3136篇 |
2013年 | 3513篇 |
2012年 | 4839篇 |
2011年 | 5006篇 |
2010年 | 3480篇 |
2009年 | 2834篇 |
2008年 | 3393篇 |
2007年 | 3233篇 |
2006年 | 2837篇 |
2005年 | 2497篇 |
2004年 | 1902篇 |
2003年 | 1806篇 |
2002年 | 1521篇 |
2001年 | 998篇 |
2000年 | 767篇 |
1999年 | 487篇 |
1998年 | 311篇 |
1997年 | 244篇 |
1996年 | 182篇 |
1995年 | 155篇 |
1994年 | 136篇 |
1993年 | 87篇 |
1992年 | 110篇 |
1991年 | 79篇 |
1990年 | 51篇 |
1989年 | 45篇 |
1988年 | 31篇 |
1987年 | 31篇 |
1986年 | 26篇 |
1985年 | 14篇 |
1984年 | 12篇 |
1983年 | 10篇 |
1982年 | 7篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1979年 | 21篇 |
1977年 | 5篇 |
1976年 | 8篇 |
1970年 | 4篇 |
1969年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
991.
目的研究不同浓度罗汉松醇提物调血脂及抗氧化的作用。方法通过自制高脂饲料喂养昆明雄性小鼠,构建高血脂症模型,给药4周,测定小鼠血清中总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、谷丙转氨酶(GPT/ALT)、谷草转氨酶(GOT/AST)和丙二醛(MDA)的含量以及超氧化物歧化酶(SOD)活力,计算脏器指数、动脉硬化指数(AI),并观察肝脏病理切片。结果相比于模型对照组,95%醇提物在给药30d后,小鼠血清中TC、TG、LDL-C、AST、ALT及肝指数均有显著性降低(P0.05,P0.01),并显著提高HDL-C水平(P0.01),也能显著的提高SOD活力和降低小鼠血清中MDA的含量(P0.01),由计算出的AI值,也能看出其在降低动脉硬化指数有显著性的效果(P0.01)。结论不同浓度的罗汉松实醇提物有降血脂、保肝及抗氧化的作用,为罗汉松实的临床应用提供依据。 相似文献
992.
目的:观察自制灭蟑胶饵的适口性和现场防治效果。方法参照GBT 13917.7-2009试验方法,对自制胶饵和氟虫腈颗粒剂的24 h摄食量进行记录,逐日观察死亡试虫数,并计算毒饵的24 h失水率和摄食比;现场试验在蜚蠊侵害严重的舰船上进行,观察记录施用胶饵后不同时间的密度指数变化情况。结果2种毒饵48 h死亡率均为100.0%,达到了国标A级,但2组试验中毒饵和饲料的比值分别为1.34和0.40,差异明显。现场投放胶饵2周后的密度指数下降80%,4~8周后即能将虫害控制在一个较低的水平。结论自制胶饵比颗粒剂剂型有更好的适口性,可在蜚蠊侵害严重的场所推广使用,实现对虫害的长期有效控制。 相似文献
993.
目的:探索血清同型半胱氨酸(Hcy)、缺血修饰蛋白(IMA)及各炎性因子与非ST段抬高急性心肌梗死(NSTEMI)患者冠状动脉病变程度的相关性.方法:将符合入选标准并经临床确诊的96例NSTEMI患者作为研究组,另外选择30例健康体检者作为对照组,检测其血清Hcy、IMA及肿瘤坏死因子-α(TNF-α)、超敏C-反应蛋白(hs-CRP)、白介素-6(IL-6)水平,并分析各因子与NSTEMI患者冠状动脉病变程度的相关性.结果:NSTEMI患者Hcy、IMA及TNF-α、IL-6、hs-CRP水平与健康对照组比较均有明显增加,且差异存在统计学意义(P<0.05);NSTEMI冠状动脉双支病变组患者Hcy、IMA及TNF-α、IL-6、hs-CRP水平与单支病变组进行比较均有明显增加,而多支病变组患者上述各项指标与双支病变组进行比较均有明显增加,且各组间差异均存在统计学意义(P<0.05);Hcy、IMA及TNF-α、IL-6、hs-CRP水平与冠状动脉病变程度均呈明显正相关(P<0.05).结论:非ST段抬高急性心肌梗死患者Hcy、IMA及TNF-α、IL-6、hs-CRP水平均较健康对照组明显增加,且随患者冠状动脉病变程度增加而增加. 相似文献
994.
Ki Hyun Lee MD Yu Mi Jeong MD Ji Young Jeon MD Taeseong Im MD Sheen‐Woo Lee MD PhD So Hyun Park MD Jeong Ho Kim MD 《Journal of clinical ultrasound : JCU》2018,46(5):358-360
We report the sonographic appearance of a rare case of neuritis ossificans of the median nerve at the wrist, which appeared as a hyperechoic lesion around the nerve. Diagnosis was confirmed with magnetic resonance imaging (MRI). 相似文献
995.
目的 观察含莫西沙星联合微卡方案治疗在耐多药肺结核(MDR-PTB)患者中的远期疗效.方法 将200例耐多药肺结核患者随机分为两组,对照组采用6 LfxZPtoPK/18LfxZPtoP治疗,实验组采用6MfxZPtoPK+微卡/18 MfxZ-PtoP+微卡治疗,疗程结束时共有121例病例完成疗程且疗末痰菌阴转,其中实验组81例痰菌阴转,对照组40例痰菌阴转,调查分析两组痰菌阴转病例2年的随访结果.结果 实验组患者治愈后6个月、1年和2年的细菌学复发率均低于对照组患者(P<0.05),而实验组患者总的细菌学复发率低于对照组患者(P<0.01).此外,实验组患者治愈后6个月、1年和2年的胸部X线病灶恶化率及总的胸部X线病灶恶化率均低于对照组患者(P<0.01).结论 莫西沙星联合微卡方案治疗耐多药结核病疗效确切、复发率低,具有很好的远期效果,值得推广使用. 相似文献
996.
Stephanie Hyeyoung Lee Ji-Yeong Lee Mi-Young Kim Yu-Jin Jeon Suyoung Kim Joon-Ho Shin 《Archives of physical medicine and rehabilitation》2018,99(8):1447-1453.e1
Objective
To compare virtual reality (VR) combined with functional electrical stimulation (FES) with cyclic FES for improving upper extremity function and health-related quality of life in patients with chronic stroke.Design
A pilot, randomized, single-blind, controlled trial.Setting
Stroke rehabilitation inpatient unit.Participants
Participants (N=48) with hemiplegia secondary to a unilateral stroke for >3 months and with a hemiplegic wrist extensor Medical Research Council scale score ranging from 1 to 3.Interventions
FES was applied to the wrist extensors and finger extensors. A VR-based wearable rehabilitation device was used combined with FES and virtual activity–based training for the intervention group. The control group received cyclic FES only. Both groups completed 20 sessions over a 4-week period.Main Outcome Measures
Primary outcome measures were changes in Fugl-Meyer Assessment–Upper Extremity and Wolf Motor Function Test scores. Secondary outcome measures were changes in Box and Block Test, Jebsen-Taylor Hand Function Test, and Stroke Impact Scale scores. Assessments were performed at baseline (t0) and at 2 weeks (t1), 4 weeks (t4), and 8 weeks (t8). Between-group comparisons were evaluated using a repeated-measures analysis of variance.Results
Forty-one participants were included in the analysis. Compared with FES alone, VR-FES produced a substantial increase in Fugl-Meyer Assessment–distal score (P=.011) and marginal improvement in Jebsen-Taylor Hand Function Test–gross score (P=.057). VR-FES produced greater, although nonsignificant, improvements in all other outcome measures, except in the Stroke Impact Scale–activities of daily living/instrumental activities of daily living score.Conclusions
FES with VR-based rehabilitation may be more effective than cyclic FES in improving distal upper extremity gross motor performance poststroke. 相似文献997.
998.
Sun Hwa Lee Seong Jong Yun Seokyong Ryu Seung Woon Choi Hye Jin Kim Tae Kyung Kang Sung Chan Oh Suk Jin Cho 《The Journal of emergency medicine》2018,54(5):607-614
Background
Neutrophil-to-lymphocyte ratio (NLR) has been used as a predictive marker for various conditions. However, there are no previous studies about NLR as a prognostic marker for acute infarction.Objective
To evaluate the potential utility of NLR as a predictor of acute infarction in acute vertigo patients without neurologic and computed tomography (CT) abnormalities.Methods
We conducted a prospective, observational study in the Emergency Department (ED) between January 2015 and December 2016. All patients underwent physical examination, laboratory tests, CT, and magnetic resonance imaging (MRI). Results of the initial and follow-up MRI with clinical progress note were considered as the reference standard. Statistically, multivariate logistic regression analysis and receiver operating characteristic (ROC) curve were used.Results
Thirty-five (25.9%) patients were diagnosed with acute infarction and 100 (74.1%) patients were diagnosed with peripheral vertigo. Horizontal nystagmus (p = 0.03; odds ratio 0.22) and NLR (p = 0.03; odds ratio 5.4) were significant factors for the differential diagnosis of acute infarction and peripheral vertigo. NLR > 2.8 showed the greatest area under the ROC curve (AUC; 0.819), optimal sensitivity (85.7%), and specificity (78.0%). NLR > 1.4 showed the highest sensitivity (97.1%) and relatively low specificity (41%). The absence of horizontal nystagmus increased the specificity (81.0%) and AUC (0.844).Conclusions
A combination of NLR > 2.8 and the absence of horizontal nystagmus is sufficiently specific for acute infarction in an ED patient with acute vertigo; thus, further testing with MRI is indicated. NLR < 2.8 by itself or combined with the presence of horizontal nystagmus is not sufficiently sensitive to rule out the need for further testing. 相似文献999.
Hirofumi Ochi Masaaki Niino Yasuhiro Onizuka Katsutoshi Hiramatsu Masakazu Hase Jang Yun André Matta Shinichi Torii 《Advances in therapy》2018,35(10):1598-1611
Introduction
The long-term safety of dimethyl fumarate (DMF) in patients with relapsing-remitting multiple sclerosis (RRMS) has been studied in mainly Caucasian patients. The present interim analysis aimed to evaluate the 72-week safety of DMF in Japanese patients with RRMS.Methods
Safety data of Japanese subjects enrolled in the 24-week randomised, double-blind, placebo-controlled APEX study (Part I) and its following open-label extension (Part II) were analysed at 72 weeks from the beginning of Part I. In Part I, subjects were randomised to DMF treatment or matching placebo while all subjects received DMF treatment during Part II. Adverse events (AEs) reported throughout the study period were recorded.Results
Overall, 109 Japanese subjects completed 72 weeks of treatment. The incidence of AEs and serious AEs was 95% and 19%, respectively, in the DMF group compared with 84% and 18%, respectively, in the placebo group at 24 weeks. Common AEs (at least 5%) reported with treatment included nasopharyngitis, flushing, hot flush, gastrointestinal events, pruritus, rash, headache, increased alanine aminotransferase (ALT) and aspartate aminotransferase (AST). AEs led to discontinuation of DMF in 5% of patients and included MS relapse, flushing, abdominal pain, liver disorder and increased ALT/AST. After an initial decrease from baseline of 17% in the DMF group at week 24, the mean lymphocyte counts stabilised and were maintained until week 72. No opportunistic/serious infections nor malignancies were reported with DMF treatment. The incidences of AEs, serious AEs, and discontinuation due to AEs were similar between the DMF and the placebo groups.Conclusion
The 72-week safety profile of DMF in Japanese patients with RRMS was consistent with previous studies that enrolled mostly Caucasian patients, with a lower incidence of flushing and related symptoms and a lower reduction in the lymphocyte count compared with previous reports.Trial Registration
ClinicalTrials.gov identifier NCT01838668.Funding
Biogen Japan Ltd.1000.
目的:探讨喉腔术后颈部解剖结构改变的患者如何选择安全有效的麻醉方法。方法:分析1例喉癌根治术后需在胸腔镜下行右肺肿瘤切除的患者的临床特征及麻醉处理过程。结果:喉切除术破坏了喉和颈部的解剖结构和生理功能,术后喉腔内出现大量瘢痕增生及肉芽生长,颈部解剖结构受到破坏,不同区域的狭窄及程度决定了麻醉方法的选择。结论:对于患有喉部疾病或者曾经因喉部疾病行气管插管全麻的患者,术前必须进行充分的气道评估,在保留自主呼吸的麻醉方式下行气管插管是相对安全的。 相似文献